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Effects of cannabidiol on contractions and calcium signaling in rat ventricular myocytes.
Ramez M. Ali1, Lina T. Al Kury1, Keun-Hang Susan Yang5, Anwar Qureshi2, Mohanraj Rajesh1,
Sehamuddin Galadari3, Yaroslav M. Shuba4, Frank Christopher Howarth2, Murat Oz1.
Laboratory of Functional Lipidomics, Department of Pharmacology, 2Department of Physiology,
3
Department of Biochemistry, College of Medicine and Health Sciences, UAE University, Al Ain, Abu
Dhabi, UAE, 4Bogomoletz Institute of Physiology and International Center of Molecular Physiology,
National Academy of Sciences of Ukraine, Kyiv-24, Ukraine, 5Department of Biological Sciences,
Schmid College of Science and Engineering, Chapman University, One University Drive, Orange, CA
92866, USA.
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Abstract
Cannabidiol (CBD), a major nonpsychotropic cannabinoid found in Cannabis plant, has been shown to
influence cardiovascular functions under various physiological and pathological conditions. In the

ip
t

present study, the effects of CBD on contractility and electrophysiological properties of rat ventricular
myocytes were investigated. Video edge detection was used to measure myocyte shortening.

cr

Intracellular Ca2+ was measured in cells loaded with the Ca2+ sensitive fluorescent indicator fura-2 AM.

us

Whole-cell patch clamp was used to measure action potential and Ca2+ currents. Radioligand binding
was employed to study pharmacological characteristics of CBD binding. CBD (1 μM) caused a

an

significant decrease in the amplitudes of electrically-evoked myocyte shortening and Ca2+ transients.
However, the amplitudes of caffeine-evoked Ca2+ transients and the rate of recovery of electrically-

M

evoked Ca2+ transients following caffeine application were not altered. Whole-cell patch-clamp
technique was employed to investigate the effect of CBD on the characteristics of action potentials

d

(APs) and L-type Ca2+ channels. CBD (1 μM) significantly decreased the duration of APs. Further

te

studies on L-type Ca2+ channels indicated that CBD inhibits these channels with IC50 of 0.1 µM in a

Ac
ce
p

voltage-independent manner. Radioligand studies indicated that the specific binding of [3H]Isradipine,
was not altered significantly by CBD. The results suggest that CBD depresses myocyte contractility by
suppressing L-type Ca2+ channels at a site different than dihydropyridine binding site and inhibits
excitation-contraction coupling in cardiomyocytes.
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Calcium channels.
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List of abbreviations: Action potential (AP); Action potential duration (APD); Action potential
duration at 60% level of repolarization (APD60); Amplitude (AMP); Bovine serum albumin (BSA);
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Cannabidiol (CBD); Δ9-tetrahydrocannabinoid (THC); Dimethylsulphoxide (DMSO); Normal Tyrode

to peak (TPK); Transient receptor potential (TRP).
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Running title: cannabidiol on excitation-contraction
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(NT); Resting cell length (RCL); Sarcoplasmic reticulum (SR); Time from peak to half (THALF); Time
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Running head: Effects of cannabidiol on rat ventricular myocytes
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Introduction
Cannabidiol (CBD) is a major nonpsychoactive phytocannabinoid found in Cannabis sativa.

ip
t

Although it is devoid of psychoactive properties, in earlier studies CBD has been shown to possess
anti-apoptotic, anti-oxidant, and anti-inflammatory effects [for reviews, 1, 2]. Interestingly, CBD

cr

displays low affinity for the cannabinoid CB1 and CB2 receptors [for reviews, 3, 4]. Thus,

pharmacological actions of CBD have been suggested to be mediated mainly by its direct actions on

us

various enzymes and ion channels or through a novel cannabinoid (non-CB1 and non-CB2) receptor [for

an

reviews, 3, 4].

Several earlier studies indicate that CBD has beneficial effects in various cardiovascular

M

pathologies such as myocardial infarction, ischemia-induced arrhythmias, and diabetic cardiomyopathy
[5, 6, 7, 8]. Although anti-oxidant and anti-inflammatory actions have been suggested to be involved in

te

d

these beneficial effects [9], the exact mechanisms of CBD actions are currently unknown.
Haeomodynamic effects of CBD have been investigated in earlier in vivo and in vitro studies

Ac
ce
p

[10]. In pentobarbitone anaesthetized rats, CBD has been shown to cause a significant but transient fall
in mean arterial blood pressure [6]. Similarly, in arterial segments taken from rat mesenteric vascular
bed that have been pre-constricted with phenylephrine, CBD has been shown to cause a concentrationdependent vasorelaxation [11]. Likewise, in rat isolated aortae, application of CBD (1-30 µM) caused
vasorelaxation. In agreement with these findings, in human mesenteric arteries, it has been shown that
CBD causes vasorelaxation of endothelin-1 pre-constricted arterial segments [12]. In these studies, both
cannabinoid receptor-dependent and independent mechanisms have been shown to play roles in CBD
inhibition of smooth muscle contraction. Further contributions to the complexity of CBD actions
include the type of vascular structure, the presence of intact endothelium, the metabolic products of
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endocannabinoids [13] and the activity of metabolizing enzymes have also been shown to modulate the
actions of CBD on cardiovascular system [10].
Compared with the information available on the vascular effects of CBD, to our knowledge,

ip
t

there have been few studies focusing on the role of CBD in the regulation of contractility and Ca2+

cr

signaling in cardiac muscle. In earlier in vitro studies, negative inotropic and bradycardic effects of
CBD have been reported [14]. In addition, in perfused rat heart, CBD has been shown to antagonize the

us

Δ9-tetrahydrocannabinoid-induced positive inotropic effect and tachycardia, one of the most consistent

an

cardiovascular effects of Cannabis intoxication [15]. In the present study, we have hypothesized that
the negative inotropic actions of CBD observed in earlier studies are due to the inhibition of excitation-

M

contraction coupling in ventricular myocytes. Thus, we have investigated the effects of CBD on

Ac
ce
p

te

d

contractility and electrical properties of acutely dissociated rat ventricular myocytes.
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Materials and Methods
Ventricular myocyte isolation
Ventricular myocytes were isolated from adult male Wistar rats (248 ± 17 g) according to

ip
t

previously described techniques [16]. This study was carried out in accordance with the

cr

recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of
Health. The protocol was approved by the Committee on the Ethics of Animal Experiments of the UAE

us

University. Briefly, the animals were euthanized using a guillotine and hearts were removed rapidly
and mounted for retrograde perfusion according to the Langendorff method. Hearts were perfused at a

an

constant flow of 8 ml g heart-1 min-1 and at 36-37 ˚C with a solution containing (mM): 130 NaCl, 5.4

M

KCl, 1.4 MgCl2, 0.75 CaCl2, 0.4 NaH2PO4, 5 HEPES, 10 glucose, 20 taurine, and 10 creatine set to pH
7.3 with NaOH. When the heart had stabilized, perfusion was continued for 4 min with Ca2+-free

d

isolation solution containing 0.1 mM EGTA, and then for 6 min with cell isolation solution containing

te

0.05 mM Ca2+, 0.75 mg/ml collagenase (type 1; Worthington Biochemical Corp, USA) and 0.075
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p

mg/ml protease (type X1 V; Sigma, Germany). Ventricles were excised from the heart, minced and
gently shaken in collagenase-containing isolation solution supplemented with 1 % BSA. Cells were
filtered from this solution at 4 minute intervals and resuspended in isolation solution containing 0.75
mM Ca2+.

Measurement of ventricular myocyte shortening
Ventricular myocytes were allowed to settle on the glass bottom of a Perspex chamber mounted
on the stage of an inverted microscope (Axiovert 35, Zeiss, Germany). Myocytes were superfused (3–5
ml/min) with normal Tyrode (NT) containing (mM): 140 NaCl, 5 KCl, 1 MgCl2, 10 glucose, 5 HEPES,
1.8 CaCl2 (pH 7.4). Shortening of myocytes was recorded using a video edge detection system (VED-
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114, Crystal Biotech, USA). Resting cell length (RCL) and amplitude of shortening (expressed as a %
of resting cell length) were measured in electrically stimulated (1 Hz) myocytes maintained at 35–36˚C.
Data were acquired and analyzed with Signal Averager software v 6.37 (Cambridge Electronic Design,

ip
t

UK). Experimental solutions were prepared from stocks immediately prior to each experiment.

cr

Measurement of intracellular Ca2+ concentration

us

Myocytes were loaded with the fluorescent indicator fura-2 AM (F-1221, Molecular Probes,
USA) as described previously [17]. In brief, 6.25 µl of a 1 mM stock solution of fura-2 AM (dissolved

an

in dimethylsulphoxide) was added to 2.5 ml of cells to give a final fura-2 concentration of 2.5 µM.
Myocytes were shaken gently for 10 min at 24 ˚C (room temperature). After loading, myocytes were

M

centrifuged, washed with NT to remove extracellular fura-2 and then left for 30 min to ensure complete
hydrolysis of the intracellular ester. To measure intracellular Ca2+concentration, myocytes were

d

alternately illuminated by 340 and 380 nm light using a monochromator (Cairn Research, UK) which

te

changed the excitation light every 2 ms. The resulting fluorescence emitted at 510 nm was recorded by

Ac
ce
p

a photomultiplier tube and the ratio of the emitted fluorescence at the two excitation wavelengths
(340/380 ratio) was calculated to provide an index of intracellular Ca2+ concentration. Resting fura-2
ratio, TPK Ca2+ transient, THALF decay of the Ca2+ transient, and the amplitude of the Ca2+ transient
were measured in electrically stimulated (1 Hz) myocytes.
Measurements of sarcoplasmic reticulum Ca2+ content
Sarcoplasmic reticulum (SR) Ca2+ release was assessed using previously described techniques
[18]. After establishing steady state Ca2+ transients in electrically stimulated (1 Hz) myocytes
maintained at 35– 36 ˚C and loaded with fura-2, stimulation was paused for a period of 5 s. Caffeine
(20 mM) was then applied for 10 s using a solution switching device customized for rapid solution
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exchange. Electrical stimulation was resumed and the Ca2+ transients were allowed to recover to steady
state. SR- releasable Ca2+ was assessed by measuring the area under the curve of the caffeine-evoked
Ca2+ transient. Fractional release of SR Ca2+ was assessed by comparing the amplitude of the

ip
t

electrically evoked steady state Ca2+ transients with that of the caffeine-evoked Ca2+ transient and
refilling of SR was assessed by measuring the rate of recovery of electrically evoked Ca2+ transients

cr

following application of caffeine.

us

Assessment of myofilament sensitivity to Ca2+

an

In some cells shortening and fura-2 ratio were recorded simultaneously. Myofilament sensitivity
to Ca2+ was assessed from phase-plane diagrams of fura-2 ratio vs. cell length by measuring the

M

gradient of the fura-2-cell length trajectory during late relaxation of the twitch contraction. The position

te

myofilament sensitivity to Ca2+ [19].

d

of the trajectory reflects the relative myofilament response to Ca2+ and hence, was used as a measure of
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ce
p

Electrophysiological measurements of action potentials
Action potentials (APs) were measured using whole-cell patch clamp technique. Recordings
were made with an Axopatch 200B amplifier (Molecular Devices, Downington, PA, USA) coupled to
an A/D interface (Digidata 1322; Molecular Devices, Downington, PA, USA). Patch pipettes were
fabricated from filamented GC150TF borosilicate glass (Harvard Apparatus, Holliston, MA, USA) on a
horizontal puller (Sutter Instruments Co., Novato, CA). Electrode resistances ranged from 2.0 to 3.0
MΩ, and seal resistances were 1-5 GΩ. After giga seal formation, the membrane was ruptured with
gentle suction to obtain whole cell current-clamp configuration. APs were elicited by injection of 0.9 to
1 nA square current pulses for 4-ms at a frequency of 0.2 Hz. Extracellular solution contained (mM):
144 NaCl, 5.4 KCl, 1.8 CaCl2, 1.2 MgCl2, 1 NaH2PO4, 10 HEPES, 10 glucose, and pH 7.4 (adjusted
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with NaOH). Recording pipettes were filled with intracellular solution containing (mM): 150 KCl, 10
NaCl, 120 aspartate, 5 MgCl2, 0.1 CaCl2, 1.1 EGTA, 10 HEPES, 4 Mg-ATP, 5 sucrose, and рН 7.2
(adjusted with HCl). Experiments were performed at room temperature (22-24 ºC). Changes of external

ip
t

solutions and application of drugs were performed using a multi-line perfusion system driven by a
micro-pump with a common outflow connected to the cell chamber. In some experiments, applications

cr

of drugs were performed using multi-barrel puffing micropipette with a common outflow positioned in

us

close proximity to the cell under investigation. Complete external solution exchange was achieved in
<1 s. In recording of Ca2+ currents, voltage pulses were elicited from a holding potential of −50 mV to

an

membrane potentials ranging from -70 mV to +70 mV in 10 mV increments every 300 ms. The wholecell bath solution contained (mM): 95 NaCl, 50 TEACl, 2 MgCl2, 2 CaCl2, 10 HEPES and 10 glucose

M

(adjusted to pH 7.35 with NaOH). The pipette solution contained (mM): 140 CsCl, 10 TEACl, 2.0

d

MgCl2, 2 HEPES 1 MgATP and 10 EGTA (adjusted to pH 7.25 with CsOH).

te

Radioligand binding studies with [3H]Isradipine
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ce
p

Experiments on the binding of [3H]Isradipine (Specific activity 58.6 Ci /mmol, New England
Nuclear, Chadds Ford, PA, USA) were conducted similar to our earlier studies [20]. Briefly, aliquots of
membranes (0.1 mg) were added to different concentrations of radiolabeled ligand to give a final
concentration of 0.02 mg/ml membranes in a total volume of 0.8 ml. After 60 min incubation at room
temperature, 0.4 ml aliquots of each sample were filtered under vacuum through Watman GF\C filters
and rapidly washed with 5 ml of ice-cold assay buffer. The filters were dried and extracted in 5 ml of
HydroflourTM (National Diagnostics, St. Louis, MO, USA) scintillation fluid before counting for 3H.
Triplicate 50-μl samples of the incubation mixtures were also counted directly for estimations of total
binding. Nonspecific binding was estimated from parallel measurements of binding in the presence of 5
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μM unlabeled nifedipine. DMSO, at the highest concentration used in our experiments (0.02 % v/v) had
no effect on the specific binding of [3H]Isradipine.
Cannabidiol (purchased from Ascent Scientific, Cambridge, UK) was dissolved in DMSO. In

ip
t

our control experiments, DMSO, at the highest concentration used (0.02 % v/v), caused 18-20 %
inhibition of the shortening in experiments lasting up to 20-25 min. Stock solutions of CBD were kept

cr

at -20 °C until its use. Reagents and chemicals used in our experiments were purchased from Sigma-

us

Aldrich (St. Louis, MO, USA). Stocks were kept at -20 °C until their use.
Data Analysis

an

Electrophysiological data were analyzed using pClamp 8.0 (Molecular Devices, Downington,
PA), Origin 8.0 (Origin Lab Corp., Northampton, MA) and Mat Lab R2011a (MathWorks Corp.,

M

Natick, MA) software. APD was measured at 60 % of repolarization from AP amplitude. The results of

d

the experiments were expressed as mean ± standard error of the mean (S.E.M.). Statistical analysis was

te

performed using the paired t-test (within the same cell analysis). Statistical significance among groups
was determined using one way ANOVA followed by Bonferroni Post-hoc analysis. Statistical analysis

Ac
ce
p

of the data was performed using Origin 7.0 software (OriginLab Corp., Northampton, MA) and IBM
SPSS statistics version 20. On all graphs (*) denotes statistical significance with P<0.05, between
specified values, or if not specified to the respective control.
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Results
Effects of cannabidiol on ventricular myocyte shortening

ip
t

In Normal Tyrode (NT) solutions, amplitudes of myocyte shortening in response to electrical
stimulation (stimulated at 1 Hz) gradually decreased to 85-80 % of controls during experiments lasting

cr

up to 20 min. No further run down of the shortening amplitudes was observed in NT solution

us

containing 0.02 % DMSO (used as vehicle in 1 µM CBD solution; data not shown; n=11; compared to
0 time point; ANOVA, P>0.05) and, unless it was stated otherwise, DMSO (in the concentration used

an

in CBD containing solution) was also included routinely in control (NT) solutions during shortening
and Ca2+ transient experiments.

M

Fig. 1A shows typical records of shortening in a myocyte superfused with either NT (in the

d

absence of CBD, NT contained 0.02 % DMSO in all experiments) or NT + 1 µM CBD and during

te

washout with NT. Time course of the effect of CBD was presented in the Fig. 1B. The effect of CBD
reached a steady level within 5 min of CBD application. Increasing the incubation time to 10 min did

Ac
ce
p

not cause further change in the amplitudes of shortening. Recovery from CBD inhibition was
incomplete during the 5-10 min washout time. In summary, the amplitude of shortening measured after
5 min bath application of CBD was significantly (paired t-test; n=17; P<0.05) reduced up to 46.4 ± 3.1
% of controls (Fig.1C). Concentration-response relationship normalized to maximal CBD inhibition
indicated that CBD suppresses shortening of amplitudes with an IC50 of 0.6 µM (Fig. 1D).
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Effects of cannabidiol on intracellular Ca2+ levels
We have investigated the effects of 5 min bath application of 1 µM CBD on the resting
intracellular Ca2+ levels and on the amplitudes and kinetics of Ca2+ transients elicited by electrical-field

ip
t

stimulation. Typical records of Ca2+ transients in a myocyte superfused with NT (containing 0.02 %

cr

DMSO), NT + 1 µM CBD and during washout with NT are shown in Fig. 2A. The effects of 1 µM
CBD on resting fura-2 ratio, TPK Ca2+ transients, THALF decay of the Ca2+ transients, and AMP of Ca2+

us

transients are shown in Fig. 2B-E, respectively. Although, CBD has been shown to alter intracellular

an

Ca2+ levels in various types of cells [for reviews, 3, 9], application of 1 µM CBD for 5 to10 min did not
cause a significant alteration in resting fura-2 ratio, TPK Ca2+ transients, and THALF decay of the Ca2+

M

transients (paired t-test; n=11-14 cells, P>0.05). However, AMP of the Ca2+ transients were
significantly reduced by 1 µM CBD (0.337 ± 0.043 fura-2 ratio units) compared to 0.488 ± 0.056 fura-2

d

ratio units (paired t-test, n =11 cells) in controls.

te

Effects of cannabidiol on sarcoplasmic reticulum Ca2+ transport

Ac
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p

Maximal amplitudes and the rates of Ca2+ release by 20 mM caffeine remained unaltered after
10 min bath application of 1 µM CBD (Figure 3A and 3B; paired t-test; n = 7 cells, P>0.05).
Fig. 3C shows a typical record illustrating the protocol used to measure fractional release of SR
Ca2+. Initially, the myocyte was electrically stimulated at 1Hz. Electrical stimulation was then turned
off for 5 s. Caffeine was then applied for 10 s using a rapid solution-exchanger device. Electrical
stimulation was then restarted, and the recovery of intracellular Ca2+ was recorded during a period of 60
s. SR Ca2+ content was assessed by measuring caffeine-evoked Ca2+ release (area under the caffeineevoked Ca2+ transient) and fractional release of Ca2+ by comparing the amplitude of the electrically
evoked steady-state Ca2+ transients with that of the caffeine-evoked Ca2+ transient in the presence of
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either NT alone or NT with 1 µM CBD. Fractional release of SR Ca2+ was not significantly altered in 1
µM CBD compared to NT (0.78 ± 0.04 in CBD versus 0.81 ± 0.07 in controls; paired t-test; n =8 cells;
Fig. 3D). The recovery of the Ca2+ transients during electrical stimulation following application of

ip
t

caffeine (Fig. 3D) was also not significantly altered in myocytes exposed to 1 µM CBD myocytes

cr

compared to control cells (paired t-test; n = 8 cells, P>0.05).
Effects of cannabidiol on myofilament sensitivity to Ca2+

us

The effects of CBD on myofilament sensitivity to Ca2+ were also investigated. These
experiments tested whether CBD decreases the mechanical responses by altering the affinity of the

an

contractile machinery of the ventricular myocytes to intracellular Ca2+. Typical record of myocyte

M

shortening, fura-2 ratio and phase-plane diagrams of fura-2 ratio vs. cell length in myocytes exposed to
NT are shown in Fig. 4A. The gradient of the trajectory reflects the relative myofilament response to

d

Ca2+ and hence, has been used as a measure of myofilament sensitivity to Ca2+ [19]. The gradients of

te

the fura-2-cell length trajectory during late relaxation of the twitch contraction measured during the
periods 500-600 ms (Fig. 4B), 500-700 ms (Fig. 4C), and 500–800 ms (Fig. 4D) were not significantly

Ac
ce
p

altered in CBD compared to NT suggesting that myofilament sensitivity to Ca2+ is not reduced by CBD
(CBD-treatment was compared to NT containing 0.02 % DMSO, paired t-test; n = 17 cells; P>0.05).
Effects of cannabidiol on the action potentials of ventricular myocytes
In this set of experiments, patch-clamped cardiomyocytes were exposed to the CBD while
continuously monitoring their Vrest and APs in the current clamp mode. The generation of APs was
evoked by 0.9-1 nA depolarizing current pulses of 4 ms duration. Since the intracellular pipette solution
did not contain Ca2+-chelating agents, the generation of each AP was accompanied by myocyte
contraction. Therefore, current pulses were applied at a frequency of 0.2 Hz. During a typical
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experiment following protocols were employed: first, whole-cell configuration was established and 4 to
5 min dialysis of the myocytes with pipette solution was allowed to ensure the equilibrium conditions
between the intracellular pipette solution and intracellular milieu. After achieving stable recordings of

ip
t

baseline electrical activity (Vrest and AP parameters), myocytes were exposed to CBD for 5 to 10 min

cr

and subsequently it was washed out.

Resting membrane potentials (means ± SEM) were -77.4 ± 1.9 and -79.2 ± 1.7 mV in control

us

and after CBD treatment (n=9) myocytes, respectively (Fig. 5A, inset and Fig. 5B). Maximal

an

amplitudes of AP and rate of rising of AP (maximal velocity; V/s, Fig. 5C and Fig 5D) were not altered
significantly in the presence of CBD. CBD (1 µM) consistently shortened the duration of AP (measured

M

at 60 % of repolarization, APD60) (Figs. 5A inset and Fig. 5E). Changes in AP shortening in response to
CBD (1 µM) application were noticeable within 20 to 30 s (inset to Fig. 5A). Recoveries were usually

Ac
ce
p

te

d

partial and required longer time.

Page 14 of 38

15
Effects of cannabidiol on L-type Ca2+ currents
We have also investigated the effect of CBD (1 µM) on the L-type Ca2+ currents (IL,Ca). Figure

ip
t

6A shows a typical record of IL,Ca elicited by applying a single 300 ms voltage pulse to +10 mV from a
holding potential of -50 mV in rat ventricular myocyte before and after 10 min superfusion with 1 µM

cr

CBD. Time course of the effect of CBD on the density of IL,Ca was presented in Figure 6B. Application
of vehicle (0.02% DMSO) for 10 min caused a 10-15% inhibition of the current density of IL,Ca in

us

experiments lasting up to 15 to 20 min. The effects of CBD were also investigated on the biophysical

an

properties of IL,Ca in rat ventricular myocytes. IL,Ca was recorded in the presence of intracellular Cs+ and
extracellular TEA+ to suppress K+ currents while retaining 95 mM Na+ in the extracellular solution.

M

Elimination of contaminating Na+ current during recording of IL,Ca was achieved by applying voltage
step-pulses from relatively depolarized Vh of -50 mV, which produced steady-state inactivation of

d

sodium channels [21]. As evident from original recordings and I-V relationships (Fig. C, D), IL,Ca

te

started to appear at Vm = -30 mV, reached maximum at around Vm = +10 mV, and decreased at higher
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p

voltages approaching zero at about Vm = +60 mV (Fig. 6D). Maximal amplitudes of IL,Ca were
suppressed in the presence of CBD (1 µM).
CBD did not change the steady-state activation curve of IL,Ca (V1/2 values in control and in the
presence of CBD are -19.1 ± 0.4 mV and -17.6 ± 0.3 mV, respectively; n=6, paired t-test, P>0.05)
(Fig.7A). However, there was a hyperpolarizing shift of IL,Ca steady-state inactivation by 9.6 mV (i.e.,
from control value V1/2= -10.2 ± 0.9 mV to V1/2= -19.8 ± 1.1 mV in the presence of CBD) (Fig 7B).
However, there was little influence on the slopes of respective curves (k = 7.7 ± 0.5 mV and k = -4.5 ±
0.4 mV for the control activation and inactivation, respectively, vs. k = 7.9 ± 0.3 mV and k = -4.2 ± 0.3
mV for the CBD-modified activation and inactivation, respectively).
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In line with earlier reports [22], kinetic analysis of I L,Ca currents were fit to double-exponential
function with fast (τf) and slow (τs) inactivation time constants. Comparison of I L,Ca currents in the
absence and presence of CBD revealed noticeable acceleration of the current's inactivation kinetics by

cr

reduced τi in the range of Vm -30 mV and +10 mV (Fig. 7C).

ip
t

CBD. Quantification of the time constants of I L,Ca inactivation showed that CBD (1 μM) significantly

us

Effects of CBD on [3H]Isradipine binding

It was possible that CBD interacts directly with the binding site of dihydropyridine class of Ca2+

an

channel antagonists on L-type Ca2+ channels. For this reason, we tested the effect of CBD on the
specific binding of [3H]Isradipine. Equilibrium curves for the binding of [3H]Isradipine, in the presence

M

and absence of the CBD are presented in Figure 8A (n= 9-11). At a concentration of 10 μM, CBD did
not cause a significant inhibition of the specific binding of [3H]Isradipine. In controls and in presence

d

of 10 μM CBD, maximum binding activities (Bmax) were 196 ± 12 and 184 ± 9 fM/mg protein, and KD

te

values were 98 ± 11 and 92 ± 8 pM, respectively. There was no statistically significant difference
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between control and CBD treated groups with respect to Bmax values (P>0.05, ANOVA, n=9-11). The
effect of increasing CBD concentration was also investigated on the specific [3H]Isradipine binding
from cardiac muscle membranes (Fig. 7C). In the concentration range used (0.1 to 30 μM), CBD did
not alter the specific binding of [3H]Isradipine.
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Discussion
The results of this study indicate for the first time that inhibition of Ca2+ signaling underlies the
negative inotropic actions of CBD in rat ventricular myocytes and that the inhibition of L-type Ca2+

ip
t

channel mediates the effects of CBD on myocyte contractility.

Administration of cannabinoids, such as THC and CBD, causes complex hemodynamic changes

cr

involving phases of both increased and decreased blood pressure as well as changes in heart rate and

us

contractility [for reviews, 10, 23]. CBD has been shown to have various effects on muscular structures,
neuronal and endothelial cells and alter the activities of several receptors, ion channels [for reviews, 3,

an

9, 24] and neurotransmitter transporters [24, 25]. However, using video edge detection system allows
measurement of contractility at single-cell level in a relatively isolated environment and excludes the

M

influence of autonomic nerve endings, gap-junctions, neurotransmitter uptake system, and coronary
perfusion status. In our experiments, CBD caused a significant reduction in the maximal shortening

te

d

amplitudes without significantly altering the time course of myocyte contraction. These findings
provide evidence that the negative inotropic effect of CBD reported in earlier studies [14, 15] results

Ac
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p

from a direct interaction of CBD with ventricular myocytes, rather than actions of CBD on nerve
endings and neurotransmitter uptake systems in the heart.
CBD has been shown to have antagonist effects on GPR55 [27]. Therefore antagonism of a
constitutive GPR55 activity can mimic the actions of CBD on the contractility of cardiomyocytes.
However, AM251, an agonist of GPR55 and antagonist/inverse agonist of CB1 receptor, does not alter
the contractility of cardiomyocytes and amplitudes of L-type Ca2+ currents [28, 29] suggesting that
antagonism of GPR55 receptors does not mediate the effects of CBD in cardiomyocytes. In several
recent studies, activation of peroxisome proliferator-activated receptor gamma (PPARγ) has been
shown to mediate the effects of CBD [13, 30]. However, PPARγ antagonist, GW9662 (1 µM, [13]), did
not reverse the effects of CBD on myocyte shortening (data not shown).
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Negative inotropic actions of CBD might be attributed to the inhibition of Ca2+ release from the
SR. In fact, CBD and other cannabinoids have been reported to modulate the ryanodine sensitive
intracellular Ca2+ stores in neurons [9, 31]. However, the amplitude and kinetics of caffeine-induced

ip
t

Ca2+ release from intracellular Ca2+ stores were not changed by CBD suggesting that ryanodinesensitive intracellular Ca2+ stores are not involved in negative inotropic effects of CBD observed in this

cr

study. CBD can alter the levels of second messengers such as cAMP, cGMP and protein kinase C

us

which are known to be involved in tuning the Ca2+ sensitivity of the contractile proteins. In an earlier
study in cardiac muscle membranes, cAMP levels have been shown to be unaltered in the presence of

an

CBD [32]. Furthermore, sensitivity of contractile proteins to intracellular Ca2+ remained unchanged in
the presence of CBD suggesting that phosphorylation and de-phosphorylation of the contractile proteins

M

do not play a significant role in negative inotropic actions of CBD. Collectively, these results suggest
that the effects of CBD on myocyte contractility are not related to changes in intracellular Ca2+ release

te

d

machinery or sensitivity of myofilaments to Ca2+. In addition, in the presence of CBD, resting levels of
intracellular Ca2+ and cell length of ventricular myocytes remained unaltered suggesting that CBD does
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not significantly affect Ca2+ homeostasis under resting conditions.
During excitation-contraction coupling, alterations in the amplitudes and kinetics of cardiac AP
are closely associated with corresponding changes in the contractility of myocytes [33]. In our study,
CBD decreased durations of APs without significantly affecting the amplitudes and dV/dtmax of APs
suggesting that voltage-gated sodium channels are not affected by CBD. In cardiac muscle,
extracellular Ca2+ required to trigger Ca2+ release from SR enters through L-type voltage-dependent
Ca2+ channels opened during the AP. Results of whole-cell patch clamp experiments indicate that, in
line with the decrease of AP duration, CBD (1-10 µM) caused a significant inhibition of voltagedependent L-type Ca2+ channels in cardiomyocytes by accelerating the inactivation of these channels.
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Left-ward (hyperpolarizing) shift of the inactivation curve, together with increased acceleration of
inactivation kinetics, indicate that more L-type Ca2+ channels would be in closed state during action
potential. Inactivation of these channels would cause shortening of action potential since the L-type
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t

Ca2+ channels are the main conductance during plateau phase (phase 2) of the ventricular action
potential. Collectively, these results suggest that during excitation-contraction coupling, shortening of

cr

action potential due to the inhibition of L-type Ca2+ channels decreases Ca2+-induced Ca2+ release from

us

SR and causes negative inotropic effect of CBD reported in earlier studies. In line with this hypothesis,
although caffeine-induced contractures and myofilament sensitivity to Ca2+ remained unchanged,

an

electrically-induced Ca2+ transients were significantly depressed by CBD; further suggesting that Ca2+induced Ca2+ release was inhibited in the presence of CBD.

M

In clinical studies, acute CBD intake does not cause a significant change in blood pressure and

d

heart rate [for a review, 10]. However, several earlier studies indicate that the increases in blood

te

pressure and heart rate during stressful conditions are markedly attenuated by CBD [34, 35, 36]. In in
vivo studies, increased heart rate and blood pressure, two of the most consistent effects of Cannabis
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intoxication, are also decreased by CBD [15]. Collectively these results suggest that CBD, at relatively
high concentrations, can suppress the function of cardiovascular system. In fact, cardiac failure due to
depressed heart contractility has been suggested to be the main cause of mortality in Cannabis
intoxication [for a review, 37]. Thus it is likely that some of the effects of Cannabis plant are mediated
by CBD during Cannabis intoxication.
In addition to cardiac contractility, the electrical activity of the heart has also been suggested to
be affected by CBD. In an earlier study, CBD has been shown to have beneficial actions in ischemiainduced cardiac arrhythmias [6]. Shortening of AP duration by CBD observed in our study can be
beneficial or harmful, depending on the underlying pathology. Thus, during acute ischemia, in which
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the duration of the cardiac APD is already shortened, a further decrease should be proarrhythmic [for a
review, 38]. However, shortening of AP duration may be beneficial in preventing those arrhythmias
caused by triggered activities observed in conditions such as heart failure [38]. In conclusion, the
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t

results indicate for the first time that CBD inhibits myocyte contractility by acting on L-type Ca2+
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channels.
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FIGURE LEGENDS

Figure 1: Effects of CBD on ventricular myocyte shortening. (A) Typical records of shortening in

ip
t

an electrically stimulated (1 Hz) ventricular myocyte superfused with either NT (containing the vehicle,
0.02% DMSO) or NT + 1 µM CBD and during washout with NT. (B) Time course of the mean

cr

amplitudes (AMP) of shortening expressed as a percentage of control values in vehicle (NT + 0.02%

us

DMSO), and in presence of CBD (1 µM). Myocytes were maintained at 35-36 °C and superfused with
CBD for 10 min. Data are shown as means ± S.E.M., n = 6-8 cells. (C) Bar graph showing the mean

an

amplitudes (AMP) of shortening expressed as a percentage of control values in the presence of vehicle,
and in presence of CBD after 10 min bath exposure to CBD (1 µM). Data are shown as means ±

M

S.E.M., n = 17 cells. * indicates statistically significant difference at the level of P < 0.05. (D)
Concentration-response curve for the inhibitory effect of CBD on myocyte shortening. The data was

d

normalized to the maximal inhibitory effect of CBD and plotted as a function of CBD concentrations.

te

Each data point represents means ± S.E.M. from n = 6-8 cells for each concentration.
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Figure 2: Effects of CBD on amplitude and time-course of intracellular Ca2+ in rat ventricular
myocytes. (A) Typical records of Ca2+ transients in an electrically stimulated (1 Hz) ventricular
myocyte superfused with either NT or NT + 1 µM CBD and during washout with NT; scale bar
indicates 0.1 fura-2 ratio unit (RU). Also shown resting fura-2 ratio (340/380 nm) (B), time to peak
(TPK) Ca2+ transient (C), time to half (THALF) decay of the Ca2+ transients (D) and amplitude (AMP) of
the Ca2+ transients (E). Myocytes were maintained at 35-36 °C and superfused with CBD for 10 min.
Data are shown as means ± SEM, n=11-14 cell. * indicates statistically significant difference at the
level of P < 0.05.
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Figure 3: Effects of CBD on sarcoplasmic reticulum Ca2+ transport. (A) Typical records illustrating
the effects of CBD on caffeine-induced Ca2+ transients. (B) Comparison of the effect of caffeine
application on the area under caffeine-evoked Ca2+ transients in NT and CBD-treated cells in rat
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ventricular myocytes. (C) Typical record illustrating the effects of electrical stimulation (ES) and rapid
application of caffeine on fura-2 ratio. (D) Mean amplitude of SR fractional release of Ca2+ (on the

cr

right) and recovery of electrically evoked intracellular Ca2+ after application of caffeine (on the left).

us

Data are shown as means ± S.E.M., n = 7-8 cells.
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Figure 4: Effects of CBD on myofilament sensitivity to Ca2+. (A) Typical record of myocyte
shortening and fura-2 ratio and phase-plane diagrams of fura-2 ratio vs. cell length in a myocytes

M

exposed to NT. The arrow indicates the region where the gradient was measured. B-D show the effect
of 1 µM CBD on the mean gradient of the fura-2 cell length trajectory of the twitch contraction during

te

± S.E.M., n = 17 cells.
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the periods 500-600 (B), 500-700 (C) and 500-800 ms (D) of late relaxation. Data are shown as means
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Figure 5: Effects of CBD on the action potentials of ventricular myocytes. (A) Representative
recordings show the APs in controls (dark grey area), in the presence of 1 μM CBD (light grey area)
and after washout (striped area) in the ventricular myocytes; the insets on panel A show the time course
of the action potential duration (APD60) and resting potential (Vrest) changes in response to CBD
application (indicated by horizontal bars). (B-E) show summary of CBD effects on amplitude and
shape of the AP in cardiomyocytes; quantification of the changes in Vrest (B), AP amplitude (C), AP
maximal rate of rise (D) and AP duration (E), characterized by APD60 in controls (dark grey bars) and
in response to 1 μM CBD (light grey bars). Data are shown as means ± S.E.M. from 6 to 9 myocytes
for each group.
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Figure 6: Effects of cannabidiol on Ca2+ currents mediated by L-type Ca2+ channels in rat
ventricular myocytes. (A) CBD inhibits L-type Ca2+ currents recorded using whole-cell voltage-clamp
mode of patch clamp technique. Current traces are recorded before (control) and after 10 min
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application of 1 μM CBD. L-type Ca2+ currents were recorded during 300 ms voltage pulses to +10 mV
from a holding potential of -50 mV. (B) Averages of the maximal currents of VGCCs presented as a

cr

function of time in the presence of vehicle (0.02% DMSO; filled circles) and 1 μM CBD (n=5 cells;

us

open circles). Application time for the agents was presented in horizontal bars. (C) Representative
recordings of ICa in response to the depicted pulse protocol under control conditions and after
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application of 1μM CBD. (D) Normalized and averaged I-V relationships of control ICa (filled circles)
and ICa in the presence of 1 μM CBD (open circles) determined by applying a series of step
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(means ± S.E.M.) are from 5 to 7 cells.
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depolarizing pulses from -70 mV to +70 mV in 10 mV increments for a duration of 300 ms. Data points

Figure 7: Effects of CBD on steady state activation and inactivation of ICa in rat ventricular
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myocytes. Steady-state activation (SSA) (A) and steady-state inactivation (SSI) (B) curves of ICa in the
absence (filled circles) and presence of 1 μM CBD (open circles). Data points (mean ± S.E.M.) are
from 5 cells. Fit of experimental data points with Boltzmann equation. (C) Voltage-dependent fast
(triangles) and slow (circles) inactivation time constants (τi) of IL,Ca under control conditions (filled
circles, and triangles) and in the presence of 1 μM CBD (open circles and triangles). Data points
(means ± S.E.M.) are from 5-6 cells.
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Fig. 8: Effects of CBD on the specific binding of [3H]Isradipine to rat ventricular muscle
membranes. (A) Specific binding as a function of the concentration of [3H]Isradipine in the absence
and presence of CBD. Data points for controls and CBD (1 μM) are indicated by filled and open
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circles, respectively. (B) Effects of increasing the concentration of CBD on the specific binding of
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[3H]Isradipine to cardiac muscle membranes. Data are the means± S.E.M. of 9-11 experiments.

Page 28 of 38

29
 Highlights
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 The effects of CBD on contractility and electrophysiological properties of rat ventricular myocytes were
investigated using video edge detection, the Ca2+ sensitive fluorescent indicator fura-2 AM, whole-cell
patch clamp, and radioligand binding methods.
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 CBD caused a significant decrease in the amplitudes of electrically-evoked myocyte shortening and
Ca2+ transients and inhibited L-type Ca2+ channels.
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 The results suggest that CBD depresses myocyte contractility by suppressing L-type Ca2+ channels at a
site different than dihydropyridine binding site and inhibits excitation-contraction coupling in
cardiomyocytes.
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